<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter" xml:lang="EN">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title>Emerging Infectious Diseases</journal-title>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18507930</article-id>
      <article-id pub-id-type="pmc">2600273</article-id>
      <article-id pub-id-type="publisher-id">07-1236</article-id>
      <article-id pub-id-type="doi">10.3201/eid1406.071236</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Acetobacter indonesiensis</italic> Pneumonia after Lung Transplant</article-title>
        <alt-title alt-title-type="running-head"><italic>Acetobacter indonesiensis</italic> Pneumonia after Lung Transplant</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bittar</surname>
            <given-names>Fadi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reynaud-Gaubert</surname>
            <given-names>Martine</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thomas</surname>
            <given-names>Pascal</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boniface</surname>
            <given-names>St&#xE9;phanie</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Raoult</surname>
            <given-names>Didier</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Rolain</surname>
            <given-names>Jean-Marc</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <aff id="aff1"><label>*</label>Unit&#xE9; de Research sur les Maladies Infectieuses et Tropicales Emergentes, Marseille, France</aff>
        <aff id="aff2"><label>&#x2020;</label>H&#xF4;pital Sainte Marguerite, Marseille</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Jean-Marc Rolain, URMITE, CNRS-IRD UMR 6236, Facult&#xE9; de M&#xE9;decine et de Pharmacie, 27 Blvd Jean Moulin, 13385 Marseille, CEDEX 5, France; email: <email xlink:href="jm.rolain@medecine.univ-mrs.fr">jm.rolain@medecine.univ-mrs.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2008</year>
      </pub-date>
      <volume>14</volume>
      <issue>6</issue>
      <fpage>997</fpage>
      <lpage>998</lpage>
      <related-article related-article-type="commentary-article" id="ra1" ext-link-type="pubmed" xlink:href="12037065" vol="40" page="2062"><string-name><surname>Coenye</surname><given-names>T</given-names> </string-name>, <string-name><surname>Goris</surname><given-names>J</given-names> </string-name>, <string-name><surname>Spilker</surname><given-names>T</given-names> </string-name>, <string-name><surname>Vandamme</surname><given-names>P</given-names> </string-name>, <string-name><surname>Lipuma</surname><given-names>JJ</given-names> </string-name>. <article-title>Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of <italic>Inquilinus limosus</italic> gen. nov., sp. nov.</article-title><source>J Clin Microbiol</source>. <year>2002</year>;<volume>40</volume>:<fpage>2062</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.40.6.2062-2069.2002</pub-id><pub-id pub-id-type="pmid">12037065</pub-id></related-article>
      <kwd-group kwd-group-type="author" xml:lang="EN">
        <title>Keywords: </title>
        <kwd>Actobacter indonesiensis</kwd>
        <kwd>cystic fibrosis</kwd>
        <kwd>colistin resistance</kwd>
        <kwd>lung transplant</kwd>
        <kwd>pneumonia</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Unusual and multiresistant bacterial infections are increasingly reported in cystic fibrosis (CF) patients (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). On January 25, 2007, a 31-year-old man with CF (mutation &#x394;F 508 and I 507) was admitted to our institution in Marseille, France, for lung transplantation. His immunosuppressive regimen included IV cyclosporin A (for the first 6 days with conversion to oral tacrolimus thereafter), azathioprine, and corticosteroids. Induction therapy that used antithymocyte globulin was administered for the first 3 days (Thymoglobuline, Genzyme Corporation, Naarden, the Netherlands). Since 2003, the patient was chronically colonized by methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA), <italic>Pseudomonas aeruginosa</italic> (susceptible only to colistin sulfomethate), and <italic>Candida albicans.</italic> Preemptive treatment with antimicrobial agents including colistin sulfomethate, tobramycin sulfate, ceftazidime, and linezolid was administered, starting on posttransplant day 1; prophylactic caspofungin, followed by inhaled amphotericin B, was given for the first month. Six and 9 days, respectively, after surgery, sputa from the patient showed <italic>P. aeruginosa</italic> and MRSA.</p>
    <p>On postoperative day 11, the patient&#x2019;s clinical condition worsened. Leukocytes increased to 13.84 &#xD7; 10<sup>9</sup>/L. In addition to <italic>P. aeruginosa</italic> (10<sup>4</sup> CFU/mL) and MRSA (10<sup>3</sup> CFU/mL), culture of later sputum samples yielded the growth of 10<sup>4</sup> CFU/mL of gram-negative, catalase-positive, and oxidase-negative bacillus (isolate 7120034) on CEPACIA agar (AES, Combourg, France) after 72 hours of incubation at 30&#xB0;C. API 20NE, API 20E, and VITEK 2 Auto system (bioM&#xE9;rieux, Marcy l&#x2019;Etoile, France) did not identify the bacillus. This bacterium was multiresistant to antimicrobial agents, including colistin, and was susceptible only to imipenem, rifampin, and aminoglycosides. The final identification of this isolate as <italic>Acetobacter indonesiensis</italic> was achieved after partial sequencing of 16S rRNA gene, as previously described (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>) (GenBank accession no. AJ199841, 99% similarity). The sequence of our isolate has been deposited in GenBank under the accession no. EF681860. The phylogenetic position of isolate 7120034 among other gram-negative bacteria is shown in the <xref ref-type="fig" rid="F1">Figure</xref>.</p>
    <fig id="F1" fig-type="figure" position="float">
      <label>Figure</label>
      <caption>
        <p>Phylogenetic tree showing the position of <italic>Acetobacter indonesiensis</italic> (isolate 7120034, GenBank accession no. EF681860), in <bold>boldface</bold>, within acetic acid bacteria and other gram-negative rods. The tree was based on 16S rDNA comparison by the neighbor-joining method. Numbers along the branches indicate bootstrap values.</p>
      </caption>
      <graphic xlink:href="07-1236-F"/>
    </fig>
    <p>Tobramycin was stopped at day 11, colistin and ceftazidime were stopped at postoperative day 14, linezolid was maintained for 10 additional days, and gentamicin (for 13 days) was added to the patient&#x2019;s drug therapy on February 10. Despite this treatment, <italic>A. indonesiensis</italic> was cultured from sputa obtained on February 16 (10<sup>4</sup> CFU/mL) and February 20 (10<sup>2</sup> CFU/mL), respectively. Six days later, leukocytes decreased to 8.62 &#xD7; 10<sup>9</sup>/L, and the patient&#x2019;s condition improved. He was discharged at the beginning of March. During 7 months of follow-up, the <italic>A. indonesiensis</italic> strain was not found again.</p>
    <p>Acetic acid bacteria are gram-negative bacilli classified into the genera <italic>Acetobacter, Gluconobacter, Gluconacetobacter, Acidomonas,</italic> and the recently described genus <italic>Asaia</italic>; these bacteria belong to the &#x3B1; subgroup of <italic>Proteobacteria</italic> (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Isolates of this family are recognized as food-associated bacteria and are able to grow at acidic pH (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). Three species have been reported as emerging pathogens in humans: <italic>Asaia bogorensis</italic> (in a case of peritonitis in a patient with a peritoneal dialysis catheter [<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>]); <italic>Granulibacter bethesdensis</italic> (in 3 cases of lymphadenitis associated with chronic granulomatous disease [<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>]); and <italic>Acetobacter cibinongensis</italic> (a recent case of bacteremia in a patient receiving chronic hemodialysis for end-stage renal failure [<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>]).</p>
    <p><italic>A. indonesiensis</italic> has been isolated from fruits and flowers in Indonesia (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>); only 3 reports on it have been published (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>,<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>,<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>). In our patient, we believe that this multidrug-resistant bacterium was the primary cause of the infection because the patient was eventually cured after an adapted antimicrobial drug therapy. Because this bacterium grows easily at acidic pH (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>), a classic condition in the CF airway surface liquid, acidity might contribute to bacterial adhesion and colonization (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>). Because acetic acid bacteria have never been isolated from human flora, the source of the contamination for our patient remains unknown.</p>
    <p>We also report the antimicrobial drug susceptibility of this bacterium. It was multiresistant, especially to colistin. Antimicrobial drug susceptibility results were obtained by using Vitek 2 Auto system because of the absence of growth on Mueller-Hinton agar. This pattern was also the case for <italic>G. bethesdensis</italic> (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). The antimicrobial susceptibility of <italic>A. cibinongensis</italic> could not be validated because of the lack of interassay reproducibility (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>). Initial antimicrobial drug therapy for this patient with amoxicillin, pristinamycin, and cefazolin did not cure the patient; he was eventually cured after the therapy was switched to tobramycin (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>).</p>
    <p>Our findings reemphasize the emergence of new colistin-resistant pathogens in CF patients, as recently reported for <italic>Inquilinus limosus</italic> (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). The increased clinical use of nebulized colistin for <italic>P. aeruginosa</italic> infection in CF patients may select specific colistin-resistant bacteria in such populations. In summary, this report of a respiratory tract infection caused by <italic>A. indonesiensis</italic> after lung transplantation in a French CF patient supports that this multidrug-resistant bacterium may be an emerging opportunistic pathogen in immunocompromized patients, including CF patients with a lung transplant.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Bittar F, Reynaud-Gaubert M, Thomas P, Boniface S, Raoult D, Rolain J-M. <italic>Acetobacter indonesiensis</italic> pneumonia after lung transplant [letter]. Emerg Infect Dis [serial on the Internet]. 2008 Jun [<italic>date cited</italic>]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/EID/content/14/6/997.htm">http://www.cdc.gov/EID/content/14/6/997.htm</ext-link></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <citation citation-type="journal"><string-name><surname>Coenye</surname> <given-names>T</given-names></string-name>, <string-name><surname>Goris</surname> <given-names>J</given-names></string-name>, <string-name><surname>Spilker</surname> <given-names>T</given-names></string-name>, <string-name><surname>Vandamme</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lipuma</surname> <given-names>JJ</given-names></string-name> <article-title>Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of <italic>Inquilinus limosus</italic> gen. nov., sp. nov.</article-title><source>J Clin Microbiol</source> <year>2002</year>;<volume>40</volume>:<fpage>2062</fpage>&#x2013;<lpage>9</lpage> <pub-id pub-id-type="doi">10.1128/JCM.40.6.2062-2069.2002</pub-id><pub-id pub-id-type="pmid">12037065</pub-id></citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <citation citation-type="journal"><string-name><surname>Drancourt</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bollet</surname> <given-names>C</given-names></string-name>, <string-name><surname>Raoult</surname> <given-names>D</given-names></string-name> <article-title><italic>Stenotrophomonas africana</italic> sp. nov., an opportunistic human pathogen in Africa.</article-title><source>Int J Syst Bacteriol</source> <year>1997</year>;<volume>47</volume>:<fpage>160</fpage>&#x2013;<lpage>3</lpage><pub-id pub-id-type="pmid">8995819</pub-id></citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <citation citation-type="journal"><string-name><surname>Cleenwerck</surname> <given-names>I</given-names></string-name>, <string-name><surname>Vandemeulebroecke</surname> <given-names>K</given-names></string-name>, <string-name><surname>Janssens</surname> <given-names>D</given-names></string-name>, <string-name><surname>Swings</surname> <given-names>J</given-names></string-name> <article-title>Re-examination of the genus <italic>Acetobacter</italic>, with descriptions of <italic>Acetobacter cerevisiae</italic> sp. nov. and <italic>Acetobacter malorum</italic> sp. nov.</article-title><source>Int J Syst Evol Microbiol</source> <year>2002</year>;<volume>52</volume>:<fpage>1551</fpage>&#x2013;<lpage>8</lpage> <pub-id pub-id-type="doi">10.1099/ijs.0.02064-0</pub-id><pub-id pub-id-type="pmid">12361257</pub-id></citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <citation citation-type="journal"><string-name><surname>Yamada</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hosono</surname> <given-names>R</given-names></string-name>, <string-name><surname>Lisdyanti</surname> <given-names>P</given-names></string-name>, <string-name><surname>Widyastuti</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Saono</surname> <given-names>S</given-names></string-name>, <string-name><surname>Uchimura</surname> <given-names>T</given-names></string-name>, <etal/><article-title>Identification of acetic acid bacteria isolated from Indonesian sources, especially of isolates classified in the genus <italic>Gluconobacter.</italic></article-title><source>J Gen Appl Microbiol</source> <year>1999</year>;<volume>45</volume>:<fpage>23</fpage>&#x2013;<lpage>8</lpage> <pub-id pub-id-type="doi">10.2323/jgam.45.23</pub-id><pub-id pub-id-type="pmid">12501398</pub-id></citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <citation citation-type="journal"><string-name><surname>Snyder</surname> <given-names>RW</given-names></string-name>, <string-name><surname>Ruhe</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kobrin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wasserstein</surname> <given-names>A</given-names></string-name>, <string-name><surname>Doline</surname> <given-names>C</given-names></string-name>, <string-name><surname>Nachamkin</surname> <given-names>I</given-names></string-name>, <etal/><article-title><italic>Asaia bogorensis</italic> peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis.</article-title><source>Am J Kidney Dis</source> <year>2004</year>;<volume>44</volume>:<fpage>e15</fpage>&#x2013;<lpage>7</lpage> <pub-id pub-id-type="doi">10.1053/j.ajkd.2004.04.042</pub-id><pub-id pub-id-type="pmid">15264206</pub-id></citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <citation citation-type="journal"><string-name><surname>Greenberg</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Ding</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zelazny</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Stock</surname> <given-names>F</given-names></string-name>, <string-name><surname>Wong</surname> <given-names>A</given-names></string-name>, <string-name><surname>Anderson</surname> <given-names>VL</given-names></string-name>, <etal/><article-title>A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease.</article-title><source>PLoS Pathog</source> <year>2006</year>;<volume>2</volume>:<fpage>e28</fpage> <pub-id pub-id-type="doi">10.1371/journal.ppat.0020028</pub-id><pub-id pub-id-type="pmid">16617373</pub-id></citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <citation citation-type="journal"><string-name><surname>Gouby</surname> <given-names>A</given-names></string-name>, <string-name><surname>Teyssier</surname> <given-names>C</given-names></string-name>, <string-name><surname>Vecina</surname> <given-names>F</given-names></string-name>, <string-name><surname>Marchandin</surname> <given-names>H</given-names></string-name>, <string-name><surname>Granolleras</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zorgniotti</surname> <given-names>I</given-names></string-name>, <etal/><article-title><italic>Acetobacter cibinongensis</italic> bacteremia in human.</article-title><source>Emerg Infect Dis</source> <year>2007</year>;<volume>13</volume>:<fpage>784</fpage>&#x2013;<lpage>5</lpage><pub-id pub-id-type="pmid">18044042</pub-id></citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <citation citation-type="journal"><string-name><surname>Lisdiyanti</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kawasaki</surname> <given-names>H</given-names></string-name>, <string-name><surname>Seki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yamada</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Uchimura</surname> <given-names>T</given-names></string-name>, <string-name><surname>Komagata</surname> <given-names>K</given-names></string-name> <article-title>Systematic study of the genus <italic>Acetobacter</italic> with descriptions of <italic>Acetobacter indonesiensis</italic> sp. nov., <italic>Acetobacter tropicalis</italic> sp. nov., <italic>Acetobacter orleanensis</italic> (Henneberg 1906) comb. nov., <italic>Acetobacter lovaniensis</italic> (Frateur 1950) comb. nov., and <italic>Acetobacter estunensis</italic> (Carr 1958) comb. nov.</article-title><source>J Gen Appl Microbiol</source> <year>2000</year>;<volume>46</volume>:<fpage>147</fpage>&#x2013;<lpage>65</lpage> <pub-id pub-id-type="doi">10.2323/jgam.46.147</pub-id><pub-id pub-id-type="pmid">12483588</pub-id></citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <citation citation-type="journal"><string-name><surname>Lisdiyanti</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kawasaki</surname> <given-names>H</given-names></string-name>, <string-name><surname>Seki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yamada</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Uchimura</surname> <given-names>T</given-names></string-name>, <string-name><surname>Komagata</surname> <given-names>K</given-names></string-name> <article-title>Identification of <italic>Acetobacter</italic> strains isolated from Indonesian sources, and proposals of <italic>Acetobacter syzygii</italic> sp. nov., <italic>Acetobacter cibinongensis</italic> sp. nov., and <italic>Acetobacter orientalis</italic> sp. nov.</article-title><source>J Gen Appl Microbiol</source> <year>2001</year>;<volume>47</volume>:<fpage>119</fpage>&#x2013;<lpage>31</lpage> <pub-id pub-id-type="doi">10.2323/jgam.47.119</pub-id><pub-id pub-id-type="pmid">12483554</pub-id></citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <citation citation-type="journal"><string-name><surname>Poschet</surname> <given-names>J</given-names></string-name>, <string-name><surname>Perkett</surname> <given-names>E</given-names></string-name>, <string-name><surname>Deretic</surname> <given-names>V</given-names></string-name> <article-title>Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment.</article-title><source>Trends Mol Med</source> <year>2002</year>;<volume>8</volume>:<fpage>512</fpage>&#x2013;<lpage>9</lpage> <pub-id pub-id-type="doi">10.1016/S1471-4914(02)02414-0</pub-id><pub-id pub-id-type="pmid">12421684</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
